Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ARCA Biopharma Inc ABIO

Healthcare Biotechnology
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company engaged in developing genetically and other targeted therapies for cardiovascular diseases through a precision medicine approach to drug development. The Company's lead product candidate is Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation (AF) in patients with chronic heart failure (HF). Gencaro is... see more

Recent & Breaking News (NDAQ:ABIO)

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM

Business Wire April 22, 2013

MGM Resorts Shares Climb Higher as Billionaire Kerkorian may Boost his Stake. Market Trades Flat on Good Economic Data

PR Newswire March 15, 2013

Free Research Reports on ABIO, KIPS, LNG and VHC Issued by the Bedford Report

Marketwired March 15, 2013

ARCA biopharma, Inc. Announces Reverse Stock Split

Business Wire March 5, 2013

Unmet Medical Need in Treatment of Heart Failure Patients with Atrial Fibrillation Highlighted in Articles in Inaugural Issue of JACC: Heart Failure

Business Wire February 6, 2013

Biotech Companies Attractive Targets for Pharma Companies Looking to Replace Lost Revenues

Marketwired February 1, 2013

Free Research Reports on ABIO, ANX, HEB and ISIS Issued by the Bedford Report

Marketwired January 31, 2013

New Adaptive Phase 3 Trial Planned for GencaroTM in Atrial Fibrillation

Business Wire January 29, 2013

GencaroTM Effect on Reducing Ventricular Arrhythmias Paper Published in Circulation: Arrhythmia and Electrophysiology

Business Wire January 3, 2013